Major drug manufacturers are literally a market sector unto themselves.
Keep Reading →
May 21 - News
Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable.
Keep Reading →
May 20 - News
MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days.
Keep Reading →
May 19 - News
Alzheimer's is a debilitating neurodegenerative disorder affecting approximately 5 million Americans, yet its causes are remarkably enigmatic. Nonetheless, pharma and biotech...
Keep Reading →
May 17 - News
Many stocks within the pharmaceutical industry have rallied significantly over the past few years and now sit at multi-year highs.
Keep Reading →
May 15 - News
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Keep Reading →
May 15 - News
Confirmation bias – one of the psychological traps investors can be most prone to falling victim to.
Keep Reading →
May 15 - News
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
May 13 - News
Big pharma isn't the first industry many investors envision when dreaming of the big profits to be made from health care stocks.
Keep Reading →
May 13 - News
Perennial underdog MannKind Corporation (NASDAQ:MNKD) could be on its countdown to liftoff.
Keep Reading →
May 10 - News
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
Keep Reading →
May 6 - News
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Keep Reading →
May 2 - News
As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares.
Keep Reading →
May 1 - Dividend Stocks, News
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Keep Reading →
May 1 - News
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) stock has a lot of negative sentiment priced into the shares, maybe too much at this point.
Keep Reading →
May 1 - News
Throughout the years, some of the best performing pharmaceutical industry stocks have had long histories of providing healthy dividends to their stockholders. Merck & Co., Inc...
Keep Reading →
April 30 - News
When I was six years old, something happened to me that I have never forgotten and will probably always live with.
Keep Reading →
April 30 - News
In January of 2012, Business Magazine released a list of the most sustainable companies in the world. You might be surprised to see who topped their list.
Keep Reading →
April 25 - News
Eli Lilly & Co. (NYSE:LLY) notched revenue of $5.60 billion. The 12 analysts polled by S&P Capital IQ expected to see a top line of $5.68 billion on the same basis.
Keep Reading →
April 24 - News
If you own Merck & Co., Inc. (NYSE:MRK) stock, you likely enjoyed the past couple of months.
Keep Reading →
April 23 - News
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
Keep Reading →
April 23 - News
If you haven't noticed, it's earnings season once again! Believe it or not, there are times when earnings reports slow down in frequency, but this is certainly not one of those...
Keep Reading →
April 21 - News
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Keep Reading →
April 20 - News
The drug produced a statistically significant improvement in three different rating scales for depression compared to placebo.
Keep Reading →
April 17 - News
Merck & Co., Inc. (NYSE:MRK) reported a 7% decline in fourth-quarter profit after the patent expiry of Singulair on August 13, 2012, in the United States.
Keep Reading →
April 16 - News
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin...
Keep Reading →
April 11 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
April 9 - News
Is AstraZeneca plc (ADR) (NYSE:AZN) worth your attention right now? The smart money is becoming less confident. The number of long hedge fund bets fell by 2 lately.
Keep Reading →
April 8 - News
Making money in business typically happens in one of two ways. You either sell a relatively low-cost product to a large number of customers.
Keep Reading →
April 4 - News
Recently, with the loss of patents causing generic competition, the main attraction to pharmaceutical companies has been their dividend.
Keep Reading →
March 29 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 27 - News
To most shareholders, hedge funds are seen as slow, outdated investment vehicles of the past.
Keep Reading →
March 27 - News
Big pharma loves Obamacare, right? After all, the main lobbying group for big pharma, the Pharmaceutical Researchers and Manufacturers of America, or PhRMA, spent $150 million...
Keep Reading →
March 23 - News
The EU's decision to seize the bank accounts of ordinary Cypriot depositors was front and center again as concerns that the financial sector could come under tremendous pressure...
Keep Reading →
March 22 - News
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is bringing its kids home.
Keep Reading →
March 22 - News
ACADIA Pharmaceuticals Inc.
Keep Reading →
March 22 - News
The demand for drugs worldwide is expected to increase due to emerging markets abroad and more specifically, due to an influx of demand from the aging "Baby Boomers" domestically...
Keep Reading →
March 20 - News
It's not uncommon for me to applaud the pharmaceutical industry as a solid long-term investment.
Keep Reading →
March 19 - News
One thing that many investors become fixated on is always wanting the next 'hot tip' or the 'inside word.' Forever seeking an edge on everyone else, investors seek the holy grail...
Keep Reading →
March 18 - News
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
Keep Reading →
March 18 - Dividend Stocks
Global pharmaceutical giants AstraZeneca plc (ADR) (NYSE:AZN), Bristol Myers Squibb Co. (NYSE:BMY), and Eli Lilly & Co. (NYSE:LLY) meet most of the growth and profitability...
Keep Reading →
March 17 - Hedge Funds
Winton Capital was founded by David Harding in 1997. Primarily a quantitative fund, it had over $25 billion in assets under management roughly a year ago.
Keep Reading →
March 15 - Hedge Funds
The company got a mid-day Food and Drug Administration approval for its lymph node diagnostic Lymphoseek.
Keep Reading →
March 14 - News
Boys will be boys. We fight, we apologize, and we enjoy some cold ones the next day like nothing happened.
Keep Reading →
March 14 - News
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Keep Reading →
March 12 - News
One of my favorite Warren Buffett quotes is that it’s far better to buy a wonderful company trading at a fair price than a fair company trading at a wonderful price. While...
Keep Reading →
March 10 - News
A common trap many investors fall into is becoming overly confident in their views. This leads to wagering too much on a single outcome.
Keep Reading →
March 7 - News
Ultimately, that was the loss of those optimists. As value investors, we are not afraid of bad news as long as we get compensated by low valuations.
Keep Reading →
March 7 - News
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 7 - News